T45.624
Poisoning by hemostatic drug, undetermined
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by hemostatic drugs refers to adverse or harmful effects resulting from an overdose or unintended use of medications designed to help control bleeding. Hemostatic drugs are used in various medical settings to promote blood clotting, especially in patients experiencing excessive bleeding or undergoing certain surgical procedures. When these medications are misused, overused, or accidentally ingested inappropriately, they can cause poisoning that may lead to serious health complications. The ICD-10 code T45.624 is assigned when the cause of such poisoning remains undetermined, indicating that the specific source or circumstances could not be definitively identified.
Causes & Symptoms
Clinical Causes: Accidental ingestion of hemostatic medication, especially in children Overdose due to incorrect dosage or prescribing errors Intentional misuse or abuse of the drug Unintentional self-medication without proper medical guidance Reactions to compounded or mislabelled medications
Key Symptoms: Localized or widespread bleeding Clot formation inappropriately leading to thrombosis Skin rash or allergic reactions Nausea and vomiting Abdominal pain Headache Signs of internal bleeding, such as hypotension or dizziness Potential signs of coagulation disturbances like bruising or petechiae
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical history review, including medication use, and physical examination. Laboratory tests are crucial and may include:
Treatment Protocols: Immediate management aims to stabilize the patient and counteract the effects of poisoning. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is T45.624 a billable ICD-10 code?
Yes, T45.624 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.624?
Clinical documentation must specify the nature of Poisoning by hemostatic drug, undetermined and any associated comorbidities for accurate reporting.
Cite this Clinical Reference